Senior insider sale
Chief Scientific Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$5.77M
300K shares
What this filing means
REICH KRISTIAN plans to sell 300K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $5.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2026ACC: 0001969223-26-000787
Officer· Chief Scientific Officer
Since Apr 2022
300K
Shares to sell
$5.77M
Approx. market value
150K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exchange of shares
NA
4/5/2023
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/5/2023 | Exchange of shares NA | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
50K
Market value
$971.3K
6/17/2026
—Completed
Units to sell
50K
Market value
$935.0K
6/16/2026
—Completed
Units to sell
50K
Market value
$944.3K
6/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
150K
Market value
$2.92M
7/15/2026
Total
Units
300K
Value
$5.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2026 | 50K | $971.3K | — | Completed |
6/16/2026 | 50K | $935.0K | — | Completed |
6/15/2026 | 50K | $944.3K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 150K | $2.92M | Nasdaq | Planned |
| Total | 300K | $5.77M | ||